EDGAR Filing Documents for 0001213900-15-001800

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001213900-15-001800

Filing Date

2015-03-16

Accepted

2015-03-16 16:12:57

Documents

Period of Report

2014-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	ANNUAL REPORT	f10k2014_actiniumpharma.htm	10-K	1172083
2	CERTIFICATE OF AMENDMENT	f10k2014ex3vii_actinium.htm	EX-3.7	17437
3	ACTINIUM PHARMACEUTICALS, INC. AMENDED AND RESTATED 2013 STOCK PLAN.	f10k2014ex10xlii_actinium.htm	EX-10.42	229491
4	CONSULTING AGREEMENT	f10k2014ex10xliii_actinium.htm	EX-10.43	45656
5	ACTINIUM PHARMACEUTICALS, INC. AMENDED AND RESTATED 2013 EQUITY INCENTIVE PLAN.	f10k2014ex10xliv_actinium.htm	EX-10.44	148795
6	LIST OF SUBSIDIARIES	f10k2014ex21i_actinium.htm	EX-21.1	812
7	ACCOUNTANT'S CONSENT	f10k2014ex23i_actinium.htm	EX-23.1	2089
8	CERTIFICATION	f10k2014ex31i_actinium.htm	EX-31.1	9116
9	CERTIFICATION	f10k2014ex31ii_actinium.htm	EX-31.2	9854
10	CERTIFICATION	f10k2014ex32i_actinium.htm	EX-32.1	4830
11	CERTIFICATION	f10k2014ex32ii_actinium.htm	EX-32.2	4946
18	GRAPHIC	image_002.gif	GRAPHIC	4536
19	GRAPHIC	img1.jpg	GRAPHIC	18925
20	GRAPHIC	img2.jpg	GRAPHIC	4737
	Complete submission text file	0001213900-15-001800.txt		7253224

Data Files

Seq	Description	Document	Type	Size
12	XBRL INSTANCE FILE	atnm-20141231.xml	EX-101.INS	786478
13	XBRL SCHEMA FILE	atnm-20141231.xsd	EX-101.SCH	62598
14	XBRL CALCULATION FILE	atnm-20141231_cal.xml	EX-101.CAL	24572
15	XBRL DEFINITION FILE	atnm-20141231_def.xml	EX-101.DEF	209328
16	XBRL LABEL FILE	atnm-20141231_lab.xml	EX-101.LAB	515488
17	XBRL PRESENTATION FILE	atnm-20141231_pre.xml	EX-101.PRE	338692

Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036

Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131

Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)